ROCKVILLE, MD., Sept. 8, 2016 -- The Regulatory Affairs Professionals Society (RAPS) today announced six regulatory experts have joined the elite ranks of RAPS Fellows. The 2016 Fellows will be honored Tuesday, 20 September, during RAPS' Regulatory Convergence conference in San Jose, CA. The Convergence is the largest annual gathering of the global regulatory profession, and RAPS' signature annual event.
The RAPS Fellows program recognizes senior regulatory professionals for their continued contributions and leadership toward the advancement of the profession and the professional. Being named a RAPS Fellow is a significant accomplishment within the regulatory profession. RAPS Fellows serve as important resources for knowledge and guidance to the organization and the profession as a whole. They may use the FRAPS designation following their names.
The 2016 RAPS Fellows are:
• Ayse Baker, FRAPS, global regulatory affairs head, GE Healthcare
• Meredith Brown-Tuttle, RAC, FRAPS, vice president, regulatory and quality, Lyric Pharmaceuticals Inc.; CEO, Regulatorium
• Nicole Landreville, RAC, FRAPS, regulatory affairs program manager, GE Healthcare
• Erin Oliver, RAC, FRAPS, global regulatory lead, Rx-to-OTC switch, GSK Consumer Healthcare
• Debra Rasmussen, RAC, FRAPS, global regulatory affairs diagnostic leader/senior director, Janssen Pharmaceutical
• Kimberly Walker, RAC, FRAPS, global RA and QA consultant, Kim Walker Consulting
More information about the Regulatory Convergence and a complete agenda of sessions and events is available at www.RAPS.org/Convergence. The Twitter hashtag for the conference is #2016RAPS.
Reporters, bloggers and other members of the media who wish to cover all or part of RAPS' Regulatory Convergence should contact Zachary Brousseau, senior manager, communications for RAPS at [email protected] or +1 301 770 2920, ext. 245. On-site registration also will be available for media with valid press credentials or a letter from an assigning editor.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Shanghai and Singapore, and chapters and affiliates worldwide. RAPS.org
CONTACT: Zachary Brousseau
Senior Manager, Communications, RAPS
+1 301 770 2920, ext. 245
[email protected]


SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Apple Turns 50: From Garage Startup to AI Crossroads
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 



